Health Encyclopedia

Home | List of Topics | Cancer | Endocrine System Cancer

Adrenocortical carcinoma

Definition

Adrenocortical carcinoma is a cancer of the adrenal glands.

Alternative Names

Tumor - adrenal

Causes, incidence, and risk factors

Adrenocortical carcinoma is most common in children younger than 5 and adults in their 30s and 40s.

Adrenocortical carcinoma may be linked to a cancer syndrome that is passed down through families (inherited). Both men and women can develop this tumor. In women the tumor often releases hormones. Adrenocortical carcinoma can produce the hormones cortisol or aldosterone.

The cause is unknown. About 2 people per million develop this type of tumor.

Symptoms

Symptoms that suggest increased cortisol production:

• Moon face: Flushed rounded face with pudgy cheeks
• Obesity
• Buffalo hump: rounded fatty hump high on the back just below the neck
• Short stature: stunted growth in height, may be less than 5th percentile
• Virilization: increased body hair (hypertrichosis) especially on face, pubic hair, acne, deepening of voice, enlarged clitoris (girls)

Symptoms that suggest increased aldosterone production are the same as symptoms of low potassium (weakness, muscle cramps, increased thirst, and urination).

Signs and tests

• High blood pressure
• High serum cortisol levels
• Low serum ACTH
• Low serum potassium
• High serum aldosterone
• CT scan of the abdomen
• Abdominal x-ray
• Abdominal MRI

Treatment

Primary treatment is surgery to remove the tumor. Adrenocortical carcinoma may not improve with chemotherapy. Medications may be given to reduce production of cortisol, which causes many of the symptoms.

Expectations (prognosis)

The outcome depends on how early the diagnosis is made and whether the tumor has spread (metastasized). Metastatic tumors are often fatal within a few years.

Complications

A complication is metastasis (often to the liver, bone, and lung).

Calling your health care provider

Call your health care provider if you or your child has symptoms of adrenocortical carcinoma, Cushing syndrome, or failure to grow.

References

Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG. Clinical Oncology. 3rd ed. Philadelphia, Pa: Churchill Livingstone, 2004.

Assié G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. January 2007;92:148-154.

Allolio B, Fassnacht M. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. June 1, 2006;91:2027-2037.

Review Date:3/13/2007
Reviewed By:Mark Levin, M.D., Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.